查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1961008

髋关节重组/置换器材市场：市场洞察、竞争格局及至2034年的市场预测

Hip Reconstruction/Replacement Devices Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

髋关节重组/置换器材市场概述

  • 全球髋关节重组/置换器材市场规模预计将从 2025 年的 92.545 亿美元成长到 2034 年的 149.1771 亿美元，展现出强劲且持续的成长动能。
  • 全球髋关节重组和置换器材市场预计在 2026 年至 2034 年的预测期内将以 5.51% 的复合年增长率成长。
  • 由于骨骼相关疾病的日益普遍、髋关节骨折病例的不断增加以及技术的持续进步，全球髋关节重组/置换器材市场正快速成长。骨关节炎和骨质疏鬆症等疾病推动了对有效关节修復方案的需求，而与老龄化相关的骨折病例的急剧增加进一步刺激了手术需求。同时，3D列印植入、混合固定係统和机器人辅助手术等创新技术正在提升植入的性能和手术精度。这些因素共同推动了市场扩张，并巩固了髋关节重组/置换器械在现代整形外科医学中的关键作用。
  • 髋关节重组/置换器材市场的主要企业包括 Zimmer Biomet、Stryker Corporation、Smith & Nephew、Exactech, Inc、Johnson & Johnson Services, Inc、Corin、Microport Scientific Corporation、Conformis、B. Braun Melsungen AG、Medacta International、DJO LLC、United Orthopedic Corporation、B. Braun Melsungen AG、Medacta International、DJO LLC、United Orthopedic Corporation. Limited、Surgival、Amplitude、DEDIENNE SANTE 和 Merete GmbH。
  • 由于髋部骨折和缺血性坏死的高发病率，北美预计将继续在髋关节重组/置换器械市场中保持主导地位。医疗保健成本的上升、产品研发的进步以及该地区主要市场参与企业对创新技术的应用，预计将在未来几年推动髋关节重组/置换器械市场的成长。
  • 根据产品类型，预计到 2025 年，全髋关节重组植入类别将占据最大的市场份额。

推动髋关节重组和置换器械市场成长的因素

  • 骨骼相关疾病的增加推动髋关节重组/置换器械市场快速增长：骨关节炎、类风湿性关节炎、缺血性坏死等骨骼相关疾病的日益普遍是推动髋关节重组/置换器械需求增长的主要因素。这些慢性疾病会导致关节进行性性退化、疼痛和活动范围受限，需要透过手术介入来恢復正常的髋关节功能。由于全球人口老化和加速肌肉骨骼劣化的生活方式因素，需要髋关节重组的患者数量正在稳步增长。这推动了对先进植入材料、微创手术和耐用假体设计的需求，从而促进了髋关节重组/置换器械市场的整体成长。
  • 主要市场参与企业产品研发活动活性化：持续的技术创新和不断增加的研发活动正显着推动髋关节重组和置换器械市场的发展。製造商正致力于开发具有更高生物相容性、耐用性和机械性能的新一代植入。诸如3D列印植入、混合固定係统和生物可吸收材料等创新技术，透过改善植入物的贴合度、减少磨损和降低术后併发症，正在改变手术效果。此外，数位化手术规划工具和机器人辅助系统的整合进一步提高了植入放置的精确度。这些进步，加上监管部门的核准和产品的上市，正在持续增强全球市场的成长和渗透率。
  • 股骨骨折发生率上升：股骨骨折发生率的上升，尤其是在老年人，是推动髋关节重组/置换器械市场发展的另一个关键因素。骨质疏鬆和跌倒导致的老龄化性骨骼脆弱是主要原因，通常需要进行部分或全髋关节置换术。全球健康统计数据显示，每年发生数百万例髋关节骨折，随着预期寿命的延长，预计这一数字将显着增加。不断扩大的患者群体对可靠耐用的植入解决方案产生了持续的需求，推动了骨水泥和非骨水泥固定係统的创新，并促进了全球髋关节重组/置换器械市场的扩张。

髋关节重组/置换器材市场报告细分

本髋关节重组/置换器材市场报告全面概​​述了全球髋关节重组/置换器材市场，重点分析了关键趋势、成长要素、挑战和机会。报告按产品类型（全髋关节置换系统、部分髋关节置换系统、髋关节重新置换系统、髋关节表面置换系统）、固定方式（有骨水泥/无骨水泥）、最终用户（医院、整形外科诊所及其他）和地区进行了详细的市场细分。本报告深入分析了北美、欧洲和亚太地区等主要市场的竞争格局、监管环境和市场动态，并详细介绍了主要行业参与企业的概况和近期产品创新，为企业提供所需数据，以识别市场潜力、制定战略计划，并在快速增长的髋关节重组/置换器械市场中把握新机会。

髋关节重组/置换装置是专门用于恢復因关节炎、骨折或其他退化性疾病导致髋关节损伤或病变患者的活动能力和缓解疼痛的整形外科植入和器械。这些装置包括股骨柄、髀臼杯、衬垫和固定係统等组件，它们协同工作以取代或重组天然关节结构。透过模拟正常髋关节的生物力学，这些装置可在置换术髋关节置换术、部分髋关节置换术或重新置换置换术后提供更佳的功能、稳定性和长期耐用性。

髋重组/置换器材市场正经历强劲成长，这主要归因于多种相互关联的因素，包括骨骼相关疾病的增加、髋关节骨折病例的增加以及产品研发的不断进步。类风湿性关节炎、类风湿性关节炎和骨质疏鬆症等疾病发病率的上升，导致旨在恢復关节活动范围和缓解疼痛的手术干预激增，从而推动了对先进植入解决方案的需求。

同时，全球髋关节骨折病例的增加，尤其是在老年族群中，由于老龄化相关的骨骼脆弱性和跌倒，进一步推动了对有效重组和置换手术的需求。为此，製造商正在加速研发，并推出创新技术，例如3D列印植入、混合固定係统和生物可吸收材料，以提高植入的耐用性、贴合度和生物相容性。数位化规划工具和机器人辅助系统的整合也提高了手术的精确度和效果。这些趋势共同推动了髋关节重组和置换器械的普及和全球渗透，为未来几年持续成长创造了有利的市场环境。

最新髋关节重组/置换器材市场的市场动态和趋势是什么？

肌肉骨骼疾病和退化性关节疾病的日益普遍，正显着推动全球对髋关节重组/置换装置的需求。根据DelveInsight估计（2024年），全球平均约有3.45亿人将罹患骨关节炎。其中，73%的患者年龄在55岁及以上，60%为女性。此外，同一资讯来源也指出，全球有1,350万人患有类风湿性关节炎。髋关节重组/置换装置对于缓解晚期关节退化性疾病患者的疼痛和恢復其活动能力至关重要。这些装置透过外科手术植入，有助于提高患者的生活品质和功能，对于满足日益增长的关节炎有效治疗需求至关重要。

此外，预计到2050年，亚洲将占骨质疏鬆性髋部骨折病例的50%至60%以上。同时，预计到2050年，全球髋部骨折病例将从700万例增加到2,100万例。全球股骨骨折病例的急剧增加凸显了对髋关节重组/置换装置日益增长的需求。这些装置在应对日益增加的髋关节损伤方面发挥关键作用，为恢復患者的活动能力和功能提供了有效的解决方案，同时也满足了骨折发生率上升所带来的日益增长的需求。

主要市场参与企业活性化产品研发力度，预计也将促进髋关节置换器材市场的成长。例如，2024年2月，史赛克公司宣布推出新的关节重建技术，并对其Mako手术机器人平台进行升级。该公司也致力于减少某些髋关节置换术中对术中透视的需求。

此外，2023年8月，全球医疗技术公司史密斯医疗（Smith & Nephew）宣布在印度推出其OR3O双动髋关节置换系统，用于初次和重新置换髋关节置换术。与传统方案相比，这款双动植入采用直径较小的股骨头，固定在较大的聚乙烯衬垫中，从而提供更高的稳定性、更低的脱位风险和更佳的活动范围。

因此，上述因素综合起来预计将在预测期内推动髋关节重组/置换器械市场的整体发展。

然而，全球髋关节重组/置换器械市场成长面临的主要限制因素是术后併发症和植入相关风险。髋关节重组或置换手术可能导致神经和血管损伤，进而引起出血、关节周围僵硬和活动范围受限。此外，植入植入过程中造成的神经损伤可能导致长期麻木、肌肉无力和持续性疼痛，对患者的復原和满意度产生负面影响。这些併发症不仅影响临床疗效，还会增加再次手术和术后照护的需求，最终导致整体医疗保健成本上升。由于患者和医疗服务提供者都希望获得更安全、更可靠、副作用更小的植入技术，这些风险对市场成长构成了重大挑战。

髋关节重组/置换器材市场区隔分析

髋关节重组/置换器材市场 - 依产品类型（全髋关节置换系统、部分髋关节置换系统、重新置换系统、表面置换系统）、固定方式（骨水泥/非骨水泥）、最终用户（医院、整形外科诊所、其他）、地区（北美、欧洲、亚太、其他）划分

按地区分類的髋关节重组/置换器材市场分析

北美髋关节重组与置换器材市场趋势

预计到2025年，北美（以美国主导）将占据全球髋关节重组/置换器械市场43%的主导份额，主要归因于髋关节骨折和缺血性坏死的高发生率。未来几年，医疗保健成本的上升、产品研发的进步以及该地区主要市场参与企业对创新技术的应用，预计将推动髋关节重组/置换器材市场的成长。

根据DelveInsight的一项分析（2024年），美国每年将有超过30,500人发生髋部骨折，其中大多数为65岁及以上的老年人，他们因在家中或社区跌倒而受伤。据估计，髋部骨折患者在骨折后的第一年将花费约40,000美元，而美国每年治疗髋部骨折的总费用超过170亿美元。髋关节重组/置换装置在髋部骨折的治疗中发挥着至关重要的作用，尤其是在老年族群中。这些装置用于恢復患者的活动能力和功能，显着促进復健并降低长期医疗保健成本。

此外，据估计，美国每年新增 20,000 至 30,000 例股骨头缺血性坏死新患者，导致每年约有 250,000 例全髋置换术。

该地区监管机构活性化产品研发力度，将进一步扩大髋关节重组/置换器材的市场。例如，2022年3月，史赛克公司宣布推出全髋关节置换和半髋关节置换术的Insignia髋关节柄。 置换术髋关节柄的设计与史赛克公司的Mako智慧机器人平台相容，该平台搭载总髋关节 4.1软体。这种整合使外科医生能够利用基于3D CT的规划数据，精确捕捉每位患者独特的解剖结构。

此外，该地区的主要企业，如 Zimmer、Stryker、强生服务公司和 Exactech 公司，占据了相当大的收入份额，也成长要素了髋关节重组/置换设备市场的成长。

因此，上述所有因素的相互作用将为北美地区的髋关节重组/置换器械市场提供有利的成长环境。

欧洲髋关节重组/置换器材市场趋势

受人口老化、肌肉骨骼疾病高发生率以及先进的整形外科医疗传统等因素的推动，欧洲髋重组/置换器材市场正经历稳定成长。德国、英国、法国和义大利等西欧国家凭藉其完善的医疗基础设施、庞大的手术量以及先进植入的广泛应用，仍然是主要的需求中心。该地区不断增长的老龄人口，加上肥胖和体能活动参与度提高等生活方式因素，持续推动初次和重新置换髋关节置换手术的需求。此外，优惠的报销政策和政府支持的医疗保健系统也提高了大多数欧洲国家的手术可及性和手术率。

技术创新持续引领欧洲市场的发展趋势。微创手术、机器人辅助髋置换术和电脑导航系统的引入，提高了手术精确度，改善了术后效果。此外，製造商正致力于生物材料创新，越来越多地采用先进陶瓷、钛合金和多孔涂层来提高骨整合和植入的耐久性。 3D列印技术和患者特异性植入设计的兴起也备受关注，使得复杂重组手术能够实现更高的个人化和生物力学动态。

此外，对研究合作、临床证据产生和数位转型的高度重视正在塑造市场格局。许多欧洲医院和整形外科中心正在整合基于人工智慧的手术规划、数据分析和结果追踪系统，以优化植入性能并支援以价值为导向的医疗服务倡议。永续性也正成为关键策略重点，製造商正采用环保的生产流程和可回收材料，以满足严格的区域环境标准。

因此，欧洲髋重组/置换器材市场正朝着更精准、个人化和永续性的方向发展。在高医疗标准、持续创新以及对数位化和机器人辅助整形外科解决方案日益重视的推动下，欧洲仍然是成熟且不断发展的下一代髋关节置换技术中心。

髋关节重组/置换器材市场的主要企业有哪些？

以下是髋关节重组/置换器材市场的主要企业，它们合计占据最大的市场份额，并主导产业趋势：

  • Zimmer Biomet
  • Stryker Corporation
  • Smith & Nephew,
  • Exactech, Inc
  • Johnson & Johnson Services, Inc
  • Corin
  • Microport Scientific Corporation
  • Conformis
  • B. Braun Melsungen AG
  • Medacta International
  • DJO LLC
  • United Orthopedic Corporation
  • Meril Life Sciences Pvt. Ltd
  • Advin Health Care
  • Auxein Medical
  • MatOrtho Limited
  • Surgival
  • Amplitude
  • DEDIENNE SANTE
  • Merete GmbH

髋关节重组/置换器材市场的竞争格局如何？

髋关节重组/置换器材市场的竞争格局由技术创新、策略整合以及对价值医疗的日益重视共同塑造。市场高度集中，由包括史赛克（Stryker）、捷迈（Zimmer Biomet）、德普（DePuy Synthes，强生公司旗下）和史密斯医疗（Smith+Nephew）在内的主要企业主导，这些企业占据了全球大部分收入。这些公司透过广泛的产品系列、全球分销网络和持续的研发投入来保持其竞争优势。创新仍然是关键的差异化因素，各公司致力于基于人工智慧的术前规划、机器人辅助手术平台以及钛合金、陶瓷和生物可吸收复合材料等先进生物材料，以提高假体的耐用性和改善患者的治疗效果。

策略联盟和收购正在进一步重塑竞争格局，企业不断拓展技术能力和地理覆盖范围，同时巩固其在微创手术和门诊髋关节手术等快速成长领域的地位。规模较小的新兴企业在3D列印、特异性植入和智慧感测器义肢等细分领域进行创新，但在扩大生产规模和遵守严格的法规方面面临挑战。

此外，服务模式的竞争也正在加剧，製造商提供数据驱动的支援、数位化手术生态系统和基于绩效的报销框架，以增强客户忠诚度。

整体而言，市场竞争格局正朝着技术整合、产品系列多元化和成本优化的方向演变。大型现有企业正透过创新和合作巩固其市场主导地位，而灵活的新参与企业则在细分领域推动技术进步，共同引领髋关节重组和置换器械市场走向更加智能、互联和以结果为导向的未来。

髋关节重组/置换器材市场的最新趋势

  • 2025 年 7 月，MatOrtho® 宣布其 ReCerf® 髋置换术(HRA) 获得 CE 标誌，确认符合欧洲安全和性能标准。
  • 2025年7月，由伦敦帝国学院衍生公司Embody Orthopaedic研发的新型髋植入获得CE认证，标誌着髋关节置换术领域的一个重要里程碑。该植入物名为H1，旨在为女性和体型较小的男性提供髋关节置换术的选择，这些群体由于解剖结构和磨损等问题，以往通常被排除在此类治疗之外。

影响分析

人工智慧驱动的创新和应用

人工智慧驱动的创新正在改变髋关节重组和置换器材市场，在整个医疗过程中提升精准度、个人化和效率。机器学习和预测分析技术分析解剖学和动态数据，从而实现针对患者的个人化植入设计，改善植入物的贴合度、对位性和长期耐用性。这种由人工智慧驱动的客製化方案可减少脱位和鬆动等併发症，促进活动能力恢復，并最大限度地减少再次手术。

在外科手术领域，人工智慧辅助规划工具、机器人系统和电脑视觉技术透过优化植入放置、提供即时决策支援和标准化复杂手术流程，正在革新手术的精准度和一致性，从而缩短手术时间、减少错误并加快患者康復。同时，在製造业领域，透过生成式建模、预测性维护和自动化品管来简化设计和生产流程，正在推动开发更轻、更强、生物相容性更好的植入。

从市场观点来看，人工智慧的整合将透过改善治疗效果和降低医疗成本来提升价值，从而增强製造商的竞争力。然而，高昂的实施成本、资料安全、模型透明度和监管障碍等挑战可能会阻碍其普及。确保资料集的多样性和公正性以及人工智慧的合乎伦理的使用对于防止治疗效果差异至关重要。

未来，人工智慧与智慧生物材料和配备感测器的植入结合，将实现术后持续监测和关节健康的预测性维护。随着检验和监管的成熟，人工智慧赋能的髋关节重组有望成为个人化整形外科的基础，从而带来更安全的手术、更好的治疗效果和更高的长期疗效。

美国关税对髋关节重组/置换器材市场的影响分析：

美国对髋关节重组和置换器械征收关税将增加整个供应链的成本并压缩利润空间，尤其是那些依赖进口原材料、专用零件（例如钴铬合金、客製化轴承）和成品植入的製造商。更高的进口关税可能会增加器械和植入零件的到岸成本，从而导致产品价格上涨或製造商利润率下降。医院和门诊手术中心的采购部门将被迫做出更严格的预算决策，这可能导致采购週期延长，并尽可能优先选择国内供应商。

供应链中断和回流奖励的影响将会加剧。虽然关税会使垂直整合或国内製造更具吸引力，并鼓励对本地生产和积层製造进行资本投资，但这些转变需要时间，这将推高短期内的资本和营运成本。规模较小、资金管道有限的原始设备製造商（OEM）可能受到的影响尤其严重。这些公司可能会将更多业务外包、进行整合或退出细分市场，这可能会降低竞争和创新的多样性。

报销和支付方趋势可能会加剧这种影响。联邦医疗保险（Medicare）、医疗补助（Medicaid）和私人保险公司对成本非常敏感，持续的价格上涨可能导致更严格的药品清单、更高的基于价值的采购标准，或者迫使医院转向使用成本更低的植入，这可能会抑制高价高端医疗器材的销售。相反，如果成本差异缩小，增加的「购买美国货」奖励和采购偏好可能会导致市场份额转移到美国製造商。

监管和合规负担与关税效应相互作用。选择在地化生产的製造商必须遵守FDA医疗设备註册、品质系统和供应验证等规定，这使得实现关税减免既耗时又昂贵。关税也可能促使企业进行垂直整合（从零件到成品），以避免关税负担，但这需要对法律规范和品质基础设施进行投资。

潜在的缓解措施和市场应对措施包括策略采购多元化、签订长期供应商协议、合法进口重新分类（一种规避关税的策略）、价格套期保值以及更多地使用国内契约製造组织（CDMO）。支付方和医疗系统可能会透过全面的价格谈判和严格的价值评估来控制整个医疗过程的整体成本。政策制定者可以透过奖励将生产迁回国内以及对关键医疗用品实行关税豁免来抵消关税的影响，从而保障医疗用品的可及性和创新性。

展望：短期内，关税将推高成本，扰乱供应商运作，并挤压中小企业生存空间。中长期来看，关税将加速国内製造业发展与产业整合，改变竞争格局，但不会消除需求。最终影响将取决于关税的规模和持续时间、国内产能的可用性以及相应的政策应对措施（采购规则、奖励和豁免）。

目录

第一章 髋关节重组/置换器材市场报告概述

2. 髋执行摘要重组/置换器材市场概要

  • 市场概览

第三章 髋关节重组/置换器材市场关键因素分析

  • 髋关节重组/置换器材市场驱动因素
    • 骨骼相关疾病增加
    • 产品开发活动增加
    • 髋部骨折增加
  • 髋关节重组/置换器材市场的限制与挑战
    • 植入相关的神经和血管损伤、出血和僵硬
    • 神经损伤会导致麻木、虚弱和疼痛
  • 髋关节重组/置换器材市场机会
    • 整合3D列印和人工智慧技术等新技术

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 我们
  • 欧洲
  • 日本
  • 中国

6. 髋关节重组/置换器材市场－波特五力分析

7. 髋关节重组/置换器材市场评估

  • 依产品类型
    • 全髋关节置换术
    • 部分髋关节置换植入术
    • 髋关节重新置换植入
    • 髋关节重组植入
  • 固定
    • 水泥
    • 非水泥
  • 最终用户
    • 医院
    • 整形外科诊所
    • 其他的
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

10. 髋关节重组/置换器材市场中的公司和产品概况

  • Stryker Corporation
  • Smith & Nephew
  • Exactech, Inc
  • Johnson & Johnson
  • Corin
  • Microport Scientific Corporation
  • Conformis
  • B. Braun Melsungen AG
  • Medacta International
  • DJO LLC
  • United Orthopedic Corporation
  • Meril Life Sciences Pvt. Ltd
  • Advin Health Care
  • Auxein Medical
  • MatOrtho Limited
  • Surgival
  • Amplitude
  • DEDIENNE SANTE
  • Merete GmbH

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0079

Hip Reconstruction/Replacement Devices Market Summary

  • The global hip reconstruction/replacement devices market is expected to increase from USD 9,254.50 million in 2025 to USD 14,917.71 million by 2034, reflecting strong and sustained growth.
  • The global hip reconstruction/replacement devices market is growing at a CAGR of 5.51% during the forecast period from 2026 to 2034.
  • The global hip reconstruction and replacement devices market is growing rapidly due to the rising prevalence of bone-related disorders, increasing hip fracture cases, and continuous technological advancements. Conditions like osteoarthritis and osteoporosis are driving the need for effective joint restoration solutions, while the surge in age-related fractures further boosts surgical demand. In parallel, innovations such as 3D-printed implants, hybrid fixation systems, and robotic-assisted procedures are enhancing implant performance and surgical precision. Together, these factors are propelling market expansion and reinforcing the critical role of hip reconstruction/replacement devices in modern orthopedic care.
  • The leading companies operating in the Hip Reconstruction/Replacement Devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exactech, Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO LLC, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, Advin Health Care, Auxein Medical, MatOrtho Limited, Surgival, Amplitude, DEDIENNE SANTE, Merete GmbH, and Others.
  • North America is expected to remain a dominant force in the hip reconstruction/replacement devices market. This is due to the high incidence of hip fractures and avascular necrosis. Escalating healthcare costs, advancements in product development, and the introduction of innovative technologies by key market players in the region are expected to drive the market for hip reconstruction/replacement devices in the forthcoming years.
  • In the product type segment of the hip reconstruction/replacement devices market, the total hip replacement implants category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Hip Reconstruction/Replacement Devices Market

  • The increasing cases of bone-related disorders leading to a surge in the hip reconstruction/replacement devices market: The growing prevalence of bone-related disorders such as osteoarthritis, rheumatoid arthritis, osteoporosis, and avascular necrosis is a major factor driving the demand for hip reconstruction and replacement devices. These chronic conditions cause progressive joint degeneration, pain, and mobility loss, necessitating surgical intervention to restore normal hip function. With an aging global population and lifestyle factors contributing to musculoskeletal deterioration, the number of patients requiring hip joint reconstruction continues to rise. Consequently, the demand for advanced implant materials, minimally invasive procedures, and durable prosthetic designs is boosting the overall growth of the hip reconstruction/replacement devices market.
  • The rising product developmental activities among key market players: Ongoing technological innovations and increased research and development activities are significantly propelling the hip reconstruction/replacement devices market. Manufacturers are focusing on developing next-generation implants that offer enhanced biocompatibility, longevity, and mechanical performance. Innovations such as 3D-printed implants, hybrid fixation systems, and bioresorbable materials are transforming surgical outcomes by improving fit, reducing wear, and minimizing postoperative complications. Additionally, the integration of digital surgical planning tools and robotic-assisted systems further supports precision in implant placement. These advancements, coupled with regulatory approvals and product launches, continue to strengthen market growth and adoption globally.
  • Increasing cases of hip fractures: The rising incidence of hip fractures, particularly among the elderly population, is another key factor accelerating the hip reconstruction/replacement devices market. Age-related bone weakening due to osteoporosis and accidental falls are leading causes of such injuries, often necessitating partial or total hip replacement surgeries. According to global health estimates, millions of hip fractures occur annually, with the number expected to increase substantially as life expectancy rises. This growing patient pool drives consistent demand for reliable and durable implant solutions, spurring innovation in cemented and non-cemented fixation systems and expanding the market for hip reconstruction and replacement devices worldwide.

Hip Reconstruction/Replacement Devices Market Report Segmentation

This hip reconstruction/replacement devices market report offers a comprehensive overview of the global hip reconstruction/replacement devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Total Hip Replacement System, Partial Hip Replacement System, Hip Revision System, and Hip Resurfacing System), Fixation (Cemented and Non-Cemented), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing hip reconstruction/replacement devices market.

The hip reconstruction/replacement devices are specialized orthopedic implants and instruments designed to restore mobility and relieve pain in patients with damaged or diseased hip joints, typically due to arthritis, fractures, or other degenerative conditions. These devices include components such as femoral stems, acetabular cups, liners, and fixation systems, which together replace or reconstruct the natural joint structure. By replicating normal hip biomechanics, they enable improved function, stability, and long-term durability following total or partial hip replacement or revision surgeries.

The hip reconstruction and replacement devices market is witnessing robust growth driven by several interrelated factors, including the increasing prevalence of bone-related disorders, rising cases of hip fractures, and ongoing advancements in product development. The growing incidence of conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis has led to a surge in surgical interventions aimed at restoring joint mobility and alleviating pain, thereby fueling demand for advanced implant solutions.

Simultaneously, the global rise in hip fractures, particularly among the elderly population due to age-related bone fragility and falls, has further amplified the need for effective reconstructive and replacement procedures. In response, manufacturers are accelerating research and development efforts to introduce innovative technologies such as 3D-printed implants, hybrid fixation systems, and bioresorbable materials that enhance implant longevity, fit, and biocompatibility. The integration of digital planning tools and robotic-assisted systems has also improved surgical precision and outcomes. Collectively, these trends are strengthening the adoption and global expansion of hip reconstruction/replacement devices, positioning the market for sustained growth in the coming years.

What are the latest Hip Reconstruction/Replacement Devices Market Dynamics and Trends?

The growing prevalence of musculoskeletal and degenerative joint diseases continues to significantly boost the demand for hip reconstruction and replacement devices worldwide. As per DelveInsight estimates (2024), approximately 345 million individuals are affected by osteoarthritis globally on average. Amongst this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Moreover, as per the same source, 13.5 million people are living with rheumatoid arthritis globally. Hip reconstruction and replacement devices are essential in alleviating pain and restoring mobility for individuals with advanced joint degeneration. Employed in surgical interventions, these devices help improve the quality of life and functionality, making them crucial in managing the increasing demand for effective solutions in arthritic conditions.

Additionally, estimates also suggest that more than 50-60% of all osteoporotic hip fractures will occur in Asia by the year 2050. In addition to this, it is also projected that the global incidence of hip fractures will rise from 7 to 21 million by 2050. The anticipated surge in hip fractures globally highlights a growing need for hip reconstruction and replacement devices. These devices play a vital role in managing the increasing number of hip injuries, offering effective solutions for restoring mobility and function, and addressing the rising demand driven by the higher incidence of fractures.

Increased product development activities by market key players are also slated to witness the market growth of hip replacement devices. For example, in February 2024, Stryker Corporation announced to showcase new joint-replacement technology and updates to its Mako surgical robotic platform. The company also aimed to reduce intraoperative fluoroscopy in certain hip-replacement procedures.

Additionally, in August 2023, Smith and Nephew, the global medical technology company, announced the launch of its OR3O Dual Mobility System for primary and revision hip arthroplasty in India. Compared to traditional solutions, the dual mobility implants featured a small-diameter femoral head that locked into a larger polyethylene insert, enhancing stability, reducing the risk of dislocation, and providing an improved range of motion.

Therefore, the factors stated above collectively will drive the overall hip reconstruction/replacement devices market during the forecast period.

However, the growth of the global hip reconstruction/replacement devices market faces notable restraints related to postoperative complications and implant-associated risks. Surgical procedures involving hip reconstruction or replacement carry the potential for nerve and blood vessel injuries, leading to bleeding, stiffness, and compromised mobility around the operated joint. Additionally, nerve damage during implantation can result in long-term numbness, muscle weakness, and persistent pain, adversely affecting patient recovery and satisfaction. These complications not only impact clinical outcomes but also increase the need for revision surgeries and postoperative care, thereby elevating overall healthcare costs. Such risks pose a significant challenge to market growth, as both patients and healthcare providers demand safer, more reliable implant technologies with minimal adverse effects.

Hip Reconstruction/Replacement Devices Market Segment Analysis

Hip Reconstruction/Replacement Devices Market by Product Type (Total Hip Replacement System, Partial Hip Replacement System, Hip Revision System, and Hip Resurfacing System), Fixation (Cemented and Non-Cemented), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Hip Reconstruction/Replacement Devices Market Regional Analysis

North America Hip Reconstruction/Replacement Devices Market Trends

North America, led by the U.S., accounted for a dominant share of 43% in the global Hip Reconstruction/Replacement Devices market in 2025. This is due to the high incidence of hip fractures and avascular necrosis. Escalating healthcare costs, advancements in product development, and the introduction of innovative technologies by key market players in the region are expected to drive the market for hip reconstruction/replacement devices in the forthcoming years.

According to DelveInsight analysis (2024), annually, over 30,500 individuals in the U.S. experience a hip fracture, with the majority occurring in those aged 65 and older due to falls in the home or community. Moreover, the estimates suggest that a patient incurs costs of approx USD 40,000 in the first year after a hip fracture, with the annual expense for hip fracture care in the U.S. exceeding USD 17 billion. Hip reconstruction and replacement devices play a crucial role in managing hip fractures, especially among older adults. They are used to restore mobility and function, significantly impacting recovery and reducing long-term healthcare costs.

Additionally, the estimates reported that in the United States, avascular necrosis of the femoral head is estimated to affect between 20,000 and 30,000 new patients each year. This condition contributes to the overall number of total hip arthroplasties performed annually, which totals approximately 250,000 procedures.

Rising product development activities by regulatory bodies in the region will further boost the market for hip reconstruction/replacement devices. For example, in addition to this, in March 2022, Stryker announced the launch of the Insignia hip stem for total hip and hemiarthroplasty procedures. The Insignia stem was designed to be compatible with Stryker's Mako SmartRobotics platform, which utilizes Total Hip 4.1 software. This integration allowed surgeons to use data from a 3D, CT-based plan to capture each patient's unique anatomy.

Additionally, the presence of key players such as Zimmer, Stryker, Johnson and Johnson Services, Inc., Exactech, Inc, among others, in the region is also a driving factor for the hip reconstruction/replacement devices market as they hold significant revenue shares.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America region in the hip reconstruction/replacement devices market.

Europe Hip Reconstruction/Replacement Devices Market Trends

The Europe hip reconstruction and replacement devices market is witnessing steady growth, supported by an aging population, high prevalence of musculoskeletal disorders, and a strong tradition of advanced orthopedic care. Western European countries such as Germany, the U.K., France, and Italy remain key demand centers due to their well-established healthcare infrastructure, high procedural volumes, and widespread adoption of technologically advanced implants. The region's growing elderly population, coupled with lifestyle factors such as obesity and increased participation in physical activities, continues to drive the need for both primary and revision hip replacement surgeries. Additionally, favorable reimbursement frameworks and government-supported healthcare systems contribute to high accessibility and procedural uptake across most European nations.

Technological advancement remains a defining trend in the European market. The adoption of minimally invasive surgical approaches, robotic-assisted hip replacement, and computer-navigated systems is enhancing procedural accuracy and improving postoperative outcomes. Moreover, manufacturers are increasingly focusing on biomaterial innovation, with growing use of advanced ceramics, titanium alloys, and porous coatings designed to enhance osseointegration and implant longevity. The emergence of 3D printing and patient-specific implant design is also gaining traction, allowing for greater customization and biomechanical precision in complex reconstructions.

The market is further shaped by a strong emphasis on research collaborations, clinical evidence generation, and digital transformation. Many hospitals and orthopedic centers in Europe are integrating AI-based surgical planning, data analytics, and outcome-tracking systems to optimize implant performance and support value-based care initiatives. Sustainability is also becoming a key strategic focus, with manufacturers adopting eco-friendly production processes and recyclable materials to meet the region's stringent environmental standards.

Hence, the Europe hip reconstruction and replacement devices market is advancing toward greater precision, personalization, and sustainability. Supported by high healthcare standards, continuous innovation, and a growing focus on digital and robotic-assisted orthopedic solutions, Europe remains a mature yet evolving hub for next-generation hip replacement technologies.

Who are the major players in the Hip Reconstruction/Replacement Devices Market?

The following are the leading companies in the hip reconstruction/replacement devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Zimmer Biomet
  • Stryker Corporation
  • Smith & Nephew,
  • Exactech, Inc
  • Johnson & Johnson Services, Inc
  • Corin
  • Microport Scientific Corporation
  • Conformis
  • B. Braun Melsungen AG
  • Medacta International
  • DJO LLC
  • United Orthopedic Corporation
  • Meril Life Sciences Pvt. Ltd
  • Advin Health Care
  • Auxein Medical
  • MatOrtho Limited
  • Surgival
  • Amplitude
  • DEDIENNE SANTE
  • Merete GmbH

How is the competitive landscape shaping the Hip Reconstruction/Replacement Devices market?

The competitive landscape of the hip reconstruction and replacement devices market is shaped by a mix of technological innovation, strategic consolidation, and growing emphasis on value-based care. The market is highly concentrated, dominated by a few key players such as Stryker, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), and Smith+Nephew, which collectively account for a major share of global revenue. These companies leverage extensive product portfolios, global distribution networks, and continuous R&D investment to maintain a competitive advantage. Innovation remains a key differentiator; firms are focusing on AI-driven preoperative planning, robotic-assisted surgery platforms, and advanced biomaterials such as titanium alloys, ceramics, and bioresorbable composites to improve implant longevity and patient outcomes.

Strategic partnerships and acquisitions are further reshaping competition, enabling companies to expand technological capabilities and geographic reach while enhancing their position in fast-growing segments like minimally invasive and outpatient hip procedures. Smaller and emerging players are contributing niche innovations, especially in 3D printing, patient-specific implants, and smart sensor-enabled prosthetics, but face challenges in scaling production and navigating stringent regulatory pathways.

Additionally, competition is intensifying around service models, with manufacturers offering data-driven support, digital surgical ecosystems, and outcome-based reimbursement frameworks to strengthen customer loyalty.

Overall, the market's competitive dynamics are evolving toward technology integration, portfolio diversification, and cost optimization. Large incumbents are consolidating their dominance through innovation and partnerships, while agile new entrants are driving niche advancements, collectively pushing the hip reconstruction and replacement devices market toward a more intelligent, connected, and outcomes-focused future.

Recent Developmental Activities in the Hip Reconstruction/Replacement Devices Market

  • In July 2025, MatOrtho(R) announced that the ReCerf(R) Hip Resurfacing Arthroplasty (HRA) received the CE mark, confirming compliance with European safety and performance standards.
  • In July 2025, a novel hip implant developed by spin-out Embody Orthopaedic of Imperial College London received the CE Mark, marking a significant milestone in hip arthroplasty. The device, known as the H1 implant, is designed to extend the option of hip resurfacing surgery to women and smaller-built men groups previously excluded from this treatment due to anatomical and wear-related issues.

Hip Reconstruction/Replacement Devices Market Segmentation

  • Hip Reconstruction/Replacement Devices by Component Exposure
  • Total Hip Replacement Implants
  • Partial Hip Replacement Implants
  • Hip Revision Implants
  • Hip Resurfacing Implants
  • Hip Reconstruction/Replacement Devices Application Exposure
  • Cemented
  • Non-cemented
  • Hip Reconstruction/Replacement Devices End-User Exposure
  • Hospitals
  • Orthopedic Clinics
  • Others
  • Hip Reconstruction/Replacement Devices Geography Exposure
  • North America Hip Reconstruction/Replacement Devices Market
  • United States Hip Reconstruction/Replacement Devices Market
  • Canada Hip Reconstruction/Replacement Devices Market
  • Mexico Hip Reconstruction/Replacement Devices Market
  • Europe Hip Reconstruction/Replacement Devices Market
  • United Kingdom Hip Reconstruction/Replacement Devices Market
  • Germany Hip Reconstruction/Replacement Devices Market
  • France Hip Reconstruction/Replacement Devices Market
  • Italy Hip Reconstruction/Replacement Devices Market
  • Spain Hip Reconstruction/Replacement Devices Market
  • Rest of Europe Hip Reconstruction/Replacement Devices Market
  • Asia-Pacific Hip Reconstruction/Replacement Devices Market
  • China Hip Reconstruction/Replacement Devices Market
  • Japan Hip Reconstruction/Replacement Devices Market
  • India Hip Reconstruction/Replacement Devices Market
  • Australia Hip Reconstruction/Replacement Devices Market
  • South Korea Hip Reconstruction/Replacement Devices Market
  • Rest of Asia-Pacific Hip Reconstruction/Replacement Devices Market
  • Rest of the World Hip Reconstruction/Replacement Devices Market
  • South America Hip Reconstruction/Replacement Devices Market
  • Middle East Hip Reconstruction/Replacement Devices Market
  • Africa Hip Reconstruction/Replacement Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the hip reconstruction and replacement devices market by driving precision, personalization, and efficiency across the care continuum. Machine learning and predictive analytics enable the design of patient-specific implants by analyzing anatomical and biomechanical data, improving fit, alignment, and long-term durability. These AI-driven customizations reduce complications such as dislocation or loosening, enhance mobility restoration, and minimize revision surgeries.

In surgery, AI-assisted planning tools, robotic systems, and computer vision technologies are revolutionizing accuracy and consistency. They optimize implant positioning, guide real-time decisions, and standardize complex procedures, leading to shorter operating times, fewer errors, and faster recovery. Meanwhile, in manufacturing, AI streamlines design and production through generative modeling, predictive maintenance, and automated quality control, enabling the development of lighter, stronger, and more biocompatible implants.

From a market perspective, AI integration enhances value by improving outcomes and reducing healthcare costs, strengthening competitiveness for manufacturers. However, challenges such as high implementation costs, data security, model transparency, and regulatory hurdles may slow adoption. Ensuring diverse, unbiased datasets and ethical AI use will be vital to prevent disparities in outcomes.

Looking ahead, the convergence of AI with smart biomaterials and sensor-enabled implants could enable continuous postoperative monitoring and predictive maintenance of joint health. As validation and regulation mature, AI-powered hip reconstruction is poised to become a cornerstone of personalized orthopedics, delivering safer surgeries, superior outcomes, and greater long-term efficiency.

U.S. Tariff Impact Analysis on the Hip Reconstruction/Replacement Devices Market:

U.S. tariffs on hip reconstruction and replacement devices would raise costs and squeeze margins across the supply chain, particularly for manufacturers that rely on imported raw materials, specialized components (e.g., cobalt-chromium alloys, custom bearings), or finished implants. Higher import duties increase landed cost for devices and implantable components, likely translating to higher list prices or reduced manufacturer margins. Hospital and ambulatory surgery center procurement teams would face tougher budget trade-offs, potentially slowing purchasing cycles or favoring domestic suppliers where available.

Supply-chain disruption and reshoring incentives would be amplified. Tariffs make vertically integrated or U.S.-based manufacturing more attractive, encouraging capital investment in local production and additive manufacturing, but those shifts take time and raise near-term capital and operating costs. Smaller OEMs that lack scale or capital access would be disproportionately affected. They may outsource more, consolidate, or exit niche segments, reducing competition and innovation variety.

Reimbursement and payer dynamics would magnify the impact. Medicare, Medicaid, and private insurers are cost-sensitive; persistent price increases could prompt tighter formularies, stricter value-based procurement, or pressure on hospitals to substitute lower-cost implants, compressing volumes for higher-priced premium devices. Conversely, stronger "buy American" incentives or procurement preferences could shift market share toward U.S. manufacturers if cost gaps narrow.

Regulatory and compliance burdens would interact with tariff effects. Manufacturers choosing to localize production must navigate FDA device registration, quality systems, and supply validation, adding time and expense before tariff-driven savings are realized. Tariffs may also spur increased vertical integration (component to finished device) to avoid duty exposure, but that requires regulatory oversight and investment in quality infrastructure.

Mitigation strategies and market responses are likely: strategic sourcing diversification, long-term supplier contracts, tariff engineering (reclassifying inputs where lawful), price hedging, and increased adoption of domestic contract manufacturers (CDMOs). Payers and health systems may negotiate bundled pricing or adopt stricter value assessments to contain total episode-of-care costs. Policymakers could counterbalance tariffs with incentives for onshoring or exemptions for critical medical supplies to preserve access and innovation.

Outlook: in the short term, tariffs raise costs, disrupt suppliers, and squeeze smaller players; in the medium-to-long term, they could accelerate domestic manufacturing and consolidation, shifting competitive dynamics but not eliminating demand. The ultimate effect depends on tariff magnitude, duration, availability of domestic capacity, and parallel policy responses (procurement rules, incentives, or exemptions).

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Hip Reconstruction/Replacement Devices market report study

  • Market size analysis for the current hip reconstruction/replacement devices market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the hip reconstruction/replacement devices market.
  • Various opportunities available for the other competitors in the hip reconstruction/replacement devices market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the hip reconstruction/replacement devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the hip reconstruction/replacement devices market growth in the future?

Frequently Asked Questions for the Hip Reconstruction/Replacement Devices Market

1. What is the growth rate of the hip reconstruction/replacement devices market?

  • The hip reconstruction/replacement devices market is estimated to grow at a CAGR of 5.51% during the forecast period from 2026 to 2034.

2. What is the market for hip reconstruction/replacement devices?

  • The Hip replacement devices market is expected to increase from USD 9,254.50 million in 2025 to USD 14,917.71 million by 20342, reflecting strong and sustained growth.

3. Which region has the highest share in the hip reconstruction/replacement devices market?

  • North America is expected to remain a dominant force in the hip reconstruction/replacement devices market. This can be ascribed to the high incidence of hip fractures and avascular necrosis. Escalating healthcare costs, advancements in product development, and the introduction of innovative technologies by key market players in the region are expected to drive the market for hip reconstruction/replacement devices during the forecast period.

4. What are the drivers for the hip reconstruction/replacement devices market?

  • The global hip reconstruction and replacement devices market is growing rapidly due to the rising prevalence of bone-related disorders, increasing hip fracture cases, and continuous technological advancements. Conditions like osteoarthritis and osteoporosis are driving the need for effective joint restoration solutions, while the surge in age-related fractures further boosts surgical demand. In parallel, innovations such as 3D-printed implants, hybrid fixation systems, and robotic-assisted procedures are enhancing implant performance and surgical precision. Together, these factors are propelling market expansion and reinforcing the critical role of hip reconstruction/replacement devices in modern orthopedic care.

5. Who are the key players operating in the hip reconstruction/replacement devices market?

  • Some of the key market players operating in the hip reconstruction/replacement devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exactech, Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO LLC, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, Advin Health Care, Auxein Medical, MatOrtho Limited, Surgival, Amplitude, DEDIENNE SANTE, Merete GmbH, and Others.

Table of Contents

1. Hip Reconstruction/Replacement Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Hip Reconstruction/Replacement Devices Market Executive Summary

  • 2.1 Market at Glance

3. Hip Reconstruction/Replacement Devices Market Key Factors Analysis

  • 3.1 Hip Reconstruction/Replacement Devices Market Drivers
    • 3.1.1 Increasing cases of bone-related disorders
    • 3.1.2 Rising product development activities
    • 3.1.3 Increasing cases of hip fractures
  • 3.2 Hip Reconstruction/Replacement Devices Market Restraints and Challenges
    • 3.2.1 Nerve and blood vessel injury, bleeding, and stiffness associated with implants
    • 3.2.2 Nerve damage causing numbness, weakness, and pain
  • 3.3 Hip Reconstruction/Replacement Devices Market Opportunity
    • 3.3.1 Integration of novel technologies such as 3-D printing & AI technology

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Hip Reconstruction/Replacement Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Hip Reconstruction/Replacement Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Total Hip Replacement Implants
    • 7.1.2 Partial Hip Replacement Implants
    • 7.1.3 Hip Revision Implants
    • 7.1.4 Hip Resurfacing Implants
  • 7.2 By Fixation
    • 7.2.1 Cemented
    • 7.2.2 Non-cemented
  • 7.3 By End-Users
    • 7.3.1 Hospitals
    • 7.3.2 Orthopedic Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.3 India Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Hip Reconstruction/Replacement Devices Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Hip Reconstruction/Replacement Devices Market Company and Product Profiles

  • 10.1 Zimmer Biomet
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Stryker Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Smith & Nephew
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Exactech, Inc
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Johnson & Johnson
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Corin
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Microport Scientific Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Conformis
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 B. Braun Melsungen AG
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Medacta International
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 DJO LLC
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 United Orthopedic Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Meril Life Sciences Pvt. Ltd
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Advin Health Care
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Auxein Medical
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 MatOrtho Limited
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Surgival
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Amplitude
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 DEDIENNE SANTE
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Merete GmbH
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Hip Reconstruction/Replacement Devices Market in Global (2023-2034)
  • Table 2: Hip Reconstruction/Replacement Devices Market in Global by Product Type (2023-2034)
  • Table 3: Hip Reconstruction/Replacement Devices Market in Global by Fixation (2023-2034)
  • Table 4: Hip Reconstruction/Replacement Devices Market in Global by End-User (2023-2034)
  • Table 5: Hip Reconstruction/Replacement Devices Market in Global by Geography (2023-2034)
  • Table 6: Hip Reconstruction/Replacement Devices Market in North America (2023-2034)
  • Table 7: Hip Reconstruction/Replacement Devices Market in the United States (2023-2034)
  • Table 8: Hip Reconstruction/Replacement Devices Market in Canada (2023-2034)
  • Table 9: Hip Reconstruction/Replacement Devices Market in Mexico (2023-2034)
  • Table 10: Hip Reconstruction/Replacement Devices Market in Europe (2023-2034)
  • Table 11: Hip Reconstruction/Replacement Devices Market in France (2023-2034)
  • Table 12: Hip Reconstruction/Replacement Devices Market in Germany (2023-2034)
  • Table 13: Hip Reconstruction/Replacement Devices Market in United Kingdom (2023-2034)
  • Table 14: Hip Reconstruction/Replacement Devices Market in Italy (2023-2034)
  • Table 15: Hip Reconstruction/Replacement Devices Market in Spain (2023-2034)
  • Table 16: Hip Reconstruction/Replacement Devices Market in the Rest of Europe (2023-2034)
  • Table 17: Hip Reconstruction/Replacement Devices Market in Asia-Pacific (2023-2034)
  • Table 18: Hip Reconstruction/Replacement Devices Market in China (2023-2034)
  • Table 19: Hip Reconstruction/Replacement Devices Market in Japan (2023-2034)
  • Table 20: Hip Reconstruction/Replacement Devices Market in India (2023-2034)
  • Table 21: Hip Reconstruction/Replacement Devices Market in Australia (2023-2034)
  • Table 22: Hip Reconstruction/Replacement Devices Market in South Korea (2023-2034)
  • Table 23: Hip Reconstruction/Replacement Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Hip Reconstruction/Replacement Devices Market in the Rest of the World (2023-2034)
  • Table 25: Hip Reconstruction/Replacement Devices Market in the Middle East (2023-2034)
  • Table 26: Hip Reconstruction/Replacement Devices Market in Africa (2023-2034)
  • Table 27: Hip Reconstruction/Replacement Devices Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

Figures 1: Hip Reconstruction/Replacement Devices Market Drivers

Figures 2: Hip Reconstruction/Replacement Devices Market Restraints

Figures 3: Hip Reconstruction/Replacement Devices Market Opportunities

Figures 4: AI-Powered Innovations in Hip Reconstruction/Replacement Devices Market

Figures 5: US Tariff Impact on Hip Reconstruction/Replacement Devices Market

Figures 6: Regulatory Analysis (US, EU, Japan, China)

Figures 7: Porter's Five Forces Analysis

Figures 8: Competitive Analysis

Figures 9: Hip Reconstruction/Replacement Devices Market in Global (2023-2034)

Figures 10: Hip Reconstruction/Replacement Devices Market in Global by Product Type (2023-2034)

Figures 11: Hip Reconstruction/Replacement Devices Market in Global by Fixation (2023-2034)

Figures 12: Hip Reconstruction/Replacement Devices Market in Global by End-User (2023-2034)

Figures 13: Hip Reconstruction/Replacement Devices Market in Global by Geography (2023-2034)

Figures 14: Hip Reconstruction/Replacement Devices Market in North America (2023-2034)

Figures 15: Hip Reconstruction/Replacement Devices Market in the United States (2023-2034)

Figures 16: Hip Reconstruction/Replacement Devices Market in Canada (2023-2034)

Figures 17: Hip Reconstruction/Replacement Devices Market in Mexico (2023-2034)

Figures 18: Hip Reconstruction/Replacement Devices Market in Europe (2023-2034)

Figures 19: Hip Reconstruction/Replacement Devices Market in France (2023-2034)

Figures 20: Hip Reconstruction/Replacement Devices Market in Germany (2023-2034)

Figures 21: Hip Reconstruction/Replacement Devices Market in United Kingdom (2023-2034)

Figures 22: Hip Reconstruction/Replacement Devices Market in Italy (2023-2034)

Figures 23: Hip Reconstruction/Replacement Devices Market in Spain (2023-2034)

Figures 24: Hip Reconstruction/Replacement Devices Market in the Rest of Europe (2023-2034)

Figures 25: Hip Reconstruction/Replacement Devices Market in Asia-Pacific (2023-2034)

Figures 26: Hip Reconstruction/Replacement Devices Market in China (2023-2034)

Figures 27: Hip Reconstruction/Replacement Devices Market in Japan (2023-2034)

Figures 28: Hip Reconstruction/Replacement Devices Market in India (2023-2034)

Figures 29: Hip Reconstruction/Replacement Devices Market in Australia (2023-2034)

Figures 30: Hip Reconstruction/Replacement Devices Market in South Korea (2023-2034)

Figures 31: Hip Reconstruction/Replacement Devices Market in Rest of Asia-Pacific (2023-2034)

Figures 32: Hip Reconstruction/Replacement Devices Market in the Rest of the World (2023-2034)

Figures 33: Hip Reconstruction/Replacement Devices Market in the Middle East (2023-2034)

Figures 34: Hip Reconstruction/Replacement Devices Market in Africa (2023-2034)

Figures 35: Hip Reconstruction/Replacement Devices Market in South America (2023-2034)

Figures 36: Competitive Landscape

Figures 37: Startup Funding & Investment Trends